CytomX Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $151.6M
Liabilities Breakdown FY2025
Total Liabilities: $52.6M
Asset Breakdown
Total Assets: $151.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $12.7M | 8.4% |
| Accounts Receivable | $2.0M | 1.3% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.3M | 0.9% |
| Goodwill | $949.0K | 0.6% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $134.6M | 88.8% |
Liabilities Breakdown
Total Liabilities: $52.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.3M | 2.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $51.3M | 97.5% |